alpha-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionate has been researched along with Reperfusion Injury in 1 studies
alpha-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionate: a glutamate agonist
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, Q | 1 |
| Liu, Y | 1 |
| Han, D | 1 |
| Xu, J | 1 |
| Zong, YY | 1 |
| Wang, Y | 1 |
| Zhang, GY | 1 |
1 other study available for alpha-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionate and Reperfusion Injury
| Article | Year |
|---|---|
Neuroprotection of GluK1 kainate receptor agonist ATPA against ischemic neuronal injury through inhibiting GluK2 kainate receptor-JNK3 pathway via GABA(A) receptors.
Topics: Animals; Enzyme Activation; gamma-Aminobutyric Acid; GluK2 Kainate Receptor; Isoxazoles; Male; Mitog | 2012 |